Middle East Conflict Risks Disrupting India's Pharmaceutical Exports and Supply Chains

India's pharmaceutical exports face potential losses of Rs 2,500 to 5,000 crore due to disruptions caused by the escalating conflict in the Middle East, particularly involving Iran. Key shipping routes like the Red Sea, Strait of Hormuz, and Gulf corridors are affected, leading to increased freight costs, rerouting, and delays. These challenges impact both raw material imports from China and exports to Gulf Cooperation Council (GCC) and West Asia-North Africa (WANA) regions, threatening supply chains and temperature-sensitive shipments. Industry bodies urge government support and alternative logistics solutions to mitigate risks.